María Luisa Gutiérrez García

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients

Manuel Romero‐Gómez, María del Mar Viloria, Raúl J. Andrade et al. · Gastroenterology · 2005 · 730 citations · Full text

Metabolic Syndrome, Diabetes Management, Hepatology +12

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

María Luisa Manzano, Rosa M. Morillas, Montserrat Garcı́a-Retortillo et al. · PLoS ONE · 2017 · 94 citations · Full text

A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis

Sonia Alonso López, María Luisa Manzano, Francisco Gea et al. · Hepatology · 2020 · 93 citations

Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis

Conrado Fernández‐Rodríguez, Julián Romero, Timothy J. Petros et al. · Liver International · 2004 · 83 citations

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

Mar Riveiro‐Barciela, David Tabernero, José Luís Calleja et al. · Digestive Diseases and Sciences · 2017 · 71 citations

Hepatology, Spanish Cohort, Viral Hepatitis +13